NCT02855944 ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Status COMPLETED Phase PHASE3
NCT02795156 Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations Status COMPLETED Phase PHASE2
NCT02671045 Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer Status TERMINATED Phase N/A
NCT02628379 Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary Status COMPLETED Phase N/A
NCT02534675 Study of Molecular Profile-Related Evidence to Determine Individualized Therapy for Advanced or Poor Prognosis Cancers Status COMPLETED Phase N/A
NCT02273336 Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer Status COMPLETED Phase N/A
NCT01987726 Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors Status COMPLETED Phase N/A
NCT01968213 Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) Status COMPLETED Phase PHASE3
NCT01939847 IMAGE Study: Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins Status COMPLETED Phase NA
NCT01891344 A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) Status COMPLETED Phase PHASE2
NCT01482715 A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) Status COMPLETED Phase PHASE1/PHASE2
NCT00578240 Molecular Studies and Clinical Correlations in Human Prostatic Disease Status ACTIVE_NOT_RECRUITING Phase N/A